Alcista
$12.28
Precio del escenario
$10.720
0.000 (0.00%)Al cierre
Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues.
Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Oaktree Acquisition III Life Sciences Corp is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not commenced any operations. The Company has not generated any revenues. It operates in the Financials sector.
Oaktree Acquisition Corp. III (OACC) is currently trading at $10.72, which is 51.2% of its 52-week range, indicating it is positioned in the middle of its price spectrum. The RSI is at 55.736, suggesting a neutral momentum, while the forward P/E ratio is currently at 0, indicating potential uncertainty in future earnings. The stock has shown a slight increase of 0.37% over the past five days, but its 20-day change is down by 0.37%, reflecting some volatility. The main risk is the current ratio, which has dropped to 0.73, indicating potential liquidity issues. Overall, while there are no immediate catalysts for a buy, the stock is stable enough to hold for the time being.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.